368 related articles for article (PubMed ID: 27807473)
1. Therapeutic Potential of Curcumin for the Treatment of Brain Tumors.
Klinger NV; Mittal S
Oxid Med Cell Longev; 2016; 2016():9324085. PubMed ID: 27807473
[TBL] [Abstract][Full Text] [Related]
2. Antitumor Activity of Curcumin in Glioblastoma.
Walker BC; Mittal S
Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33322413
[TBL] [Abstract][Full Text] [Related]
3. Curcumin, a Multifaceted Hormetic Agent, Mediates an Intricate Crosstalk between Mitochondrial Turnover, Autophagy, and Apoptosis.
Rainey NE; Moustapha A; Petit PX
Oxid Med Cell Longev; 2020; 2020():3656419. PubMed ID: 32765806
[TBL] [Abstract][Full Text] [Related]
4. Anticancer Mechanism of Curcumin on Human Glioblastoma.
Wong SC; Kamarudin MNA; Naidu R
Nutrients; 2021 Mar; 13(3):. PubMed ID: 33809462
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic Potential of Curcumin in the Treatment of Glioblastoma Multiforme.
Shahcheraghi SH; Zangui M; Lotfi M; Ghayour-Mobarhan M; Ghorbani A; Jaliani HZ; Sadeghnia HR; Sahebkar A
Curr Pharm Des; 2019; 25(3):333-342. PubMed ID: 30864499
[TBL] [Abstract][Full Text] [Related]
6. Review on the Therapeutic Potential of Curcumin and its Derivatives on Glioma Biology.
Mohamadian M; Ahmadi SS; Bahrami A; Ferns GA
Neurochem Res; 2022 Oct; 47(10):2936-2953. PubMed ID: 35790698
[TBL] [Abstract][Full Text] [Related]
7. Antiproliferative potential of piperine and curcumin in drug-resistant human leukemia cancer cells are mediated via autophagy and apoptosis induction, S-phase cell cycle arrest and inhibition of cell invasion and migration.
Li N; Wen S; Chen G; Wang S
J BUON; 2020; 25(1):401-406. PubMed ID: 32277661
[TBL] [Abstract][Full Text] [Related]
8. Curcumin induces autophagy, inhibits proliferation and invasion by downregulating AKT/mTOR signaling pathway in human melanoma cells.
Zhao G; Han X; Zheng S; Li Z; Sha Y; Ni J; Sun Z; Qiao S; Song Z
Oncol Rep; 2016 Feb; 35(2):1065-74. PubMed ID: 26573768
[TBL] [Abstract][Full Text] [Related]
9. Mechanistic Understanding of Curcumin's Therapeutic Effects in Lung Cancer.
Wan Mohd Tajuddin WNB; Lajis NH; Abas F; Othman I; Naidu R
Nutrients; 2019 Dec; 11(12):. PubMed ID: 31817718
[TBL] [Abstract][Full Text] [Related]
10. Autophagy inhibition improves the efficacy of curcumin/temozolomide combination therapy in glioblastomas.
Zanotto-Filho A; Braganhol E; Klafke K; Figueiró F; Terra SR; Paludo FJ; Morrone M; Bristot IJ; Battastini AM; Forcelini CM; Bishop AJR; Gelain DP; Moreira JCF
Cancer Lett; 2015 Mar; 358(2):220-231. PubMed ID: 25542083
[TBL] [Abstract][Full Text] [Related]
11. Curcumin induces G2/M cell cycle arrest in a p53-dependent manner and upregulates ING4 expression in human glioma.
Liu E; Wu J; Cao W; Zhang J; Liu W; Jiang X; Zhang X
J Neurooncol; 2007 Dec; 85(3):263-70. PubMed ID: 17594054
[TBL] [Abstract][Full Text] [Related]
12. Targeted therapies of curcumin focus on its therapeutic benefits in cancers and human health: Molecular signaling pathway-based approaches and future perspectives.
Islam MR; Rauf A; Akash S; Trisha SI; Nasim AH; Akter M; Dhar PS; Ogaly HA; Hemeg HA; Wilairatana P; Thiruvengadam M
Biomed Pharmacother; 2024 Jan; 170():116034. PubMed ID: 38141282
[TBL] [Abstract][Full Text] [Related]
13. Curcumin's spice-infused therapeutic promise: disease severity alleviation in a mouse model of multiple sclerosis via modulation of immune responses.
Amiri Z; Jalili S; Tarahomi M; Eslami M; Yazdanpanah E; Baharlou R; Esmaeili SA; Yousefi B; Haghmorad D
Mol Biol Rep; 2023 Nov; 50(11):8843-8853. PubMed ID: 37660318
[TBL] [Abstract][Full Text] [Related]
14. The golden spice curcumin in cancer: A perspective on finalized clinical trials during the last 10 years.
Karaboga Arslan AK; Uzunhisarcıklı E; Yerer MB; Bishayee A
J Cancer Res Ther; 2022; 18(1):19-26. PubMed ID: 35381757
[TBL] [Abstract][Full Text] [Related]
15. Curcumin: therapeutical potential in ophthalmology.
Pescosolido N; Giannotti R; Plateroti AM; Pascarella A; Nebbioso M
Planta Med; 2014 Mar; 80(4):249-54. PubMed ID: 24323538
[TBL] [Abstract][Full Text] [Related]
16. New Promising Therapeutic Avenues of Curcumin in Brain Diseases.
Benameur T; Giacomucci G; Panaro MA; Ruggiero M; Trotta T; Monda V; Pizzolorusso I; Lofrumento DD; Porro C; Messina G
Molecules; 2021 Dec; 27(1):. PubMed ID: 35011468
[TBL] [Abstract][Full Text] [Related]
17. Curcumin: preventive and therapeutic properties in laboratory studies and clinical trials.
Strimpakos AS; Sharma RA
Antioxid Redox Signal; 2008 Mar; 10(3):511-45. PubMed ID: 18370854
[TBL] [Abstract][Full Text] [Related]
18. Anti-inflammatory properties of curcumin, a major constituent of Curcuma longa: a review of preclinical and clinical research.
Jurenka JS
Altern Med Rev; 2009 Jun; 14(2):141-53. PubMed ID: 19594223
[TBL] [Abstract][Full Text] [Related]
19. The clinical applications of curcumin: current state and the future.
Fan X; Zhang C; Liu DB; Yan J; Liang HP
Curr Pharm Des; 2013; 19(11):2011-31. PubMed ID: 23116310
[TBL] [Abstract][Full Text] [Related]
20. Curcumin's Beneficial Effects on Neuroblastoma: Mechanisms, Challenges, and Potential Solutions.
Zhai K; Brockmüller A; Kubatka P; Shakibaei M; Büsselberg D
Biomolecules; 2020 Oct; 10(11):. PubMed ID: 33105719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
